Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Toll-like receptor antagonist active in autoimmune disease models

May 10, 2012

Ongoing ARVO meeting features phase II results on ACU-4429 in AMD

May 10, 2012

Novel anticancer compounds synthesized at Nerviano Medical Sciences

May 10, 2012

Researchers in Taiwan identify new candidate biomarker of kidney injury

May 9, 2012

Double-blind trial assesses secukinumab for psoriatic arthritis

May 9, 2012

Exonhit describes novel tubulin polymerization inhibitor

May 9, 2012

Genentech presents first small-molecule Ras inhibitors

May 9, 2012

New interferon-free therapy for hepatitis C is active in INFORM-SVR trial

May 9, 2012

First-in-human data disclosed on topical RNAi drug for ocular pain

May 8, 2012

Genocea Biosciences presents potential HSV-2 vaccine at ongoing conference

May 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...